相关实验视频

Updated: Jun 14, 2026

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Published on: July 2, 2016

在Ig Knockin小鼠中产生广泛中和的抗HIV-1抗体

Amelia Escolano¹, Jon M Steichen², Pia Dosenovic¹

¹Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065.

|September 10, 2016

概括

开发有效的HIV-1疫苗仍然是一个挑战. 这项研究显示,一种新的免疫策略成功地在小鼠中产生了广泛中和抗体 (bNAbs),这是保护性艾滋病毒疫苗的关键一步.

科学领域:

免疫学
疫苗学
病毒学

背景情况:

开发一种广泛中和抗体 (bNAb) 诱导的HIV-1疫苗是预防HIV的关键但尚未实现的目标.
目前的免疫策略尚未产生能够中和多种HIV-1菌株的有效bNAbs.

研究的目的:

探索新的免疫疗法,以获得针对HIV-1的广泛中和抗体 (bNAbs).
研究顺序免疫原的有效性,以引导抗体向bNAb前体成熟.

主要方法:

对表达PGT121bNAb生殖线前体的小鼠进行免疫接种.
用于激活生殖系B细胞的原始免疫原体,然后用顺序的,逐渐减少修改的免疫原体 (本地类型的trimers) 进行ELISA引导的增强.
进行了抗体克隆以分析产生的抗体.

主要成果:

序列免疫方案引起异质的二级中和抗体反应.
仅使用原始免疫原的重复免疫没有产生类似的中和反应.
抗体克隆证实诱导高体位突变水平和类似于人类bNAbs的二级中和抗体.

结论:

用专门设计的免疫原进行序列免疫,可以有效地诱导高水平的体质突变.
这一策略可以引导抗体成熟以从其推断的生殖基因前体产生bNAbs.
这些发现为开发有效的HIV-1疫苗提供了有希望的方法.

更多相关视频

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Humanized NOD/SCID/IL2rγ^null (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

相关概念视频

Inhibitors of Virion Maturation and Assembly

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...